Loading…

Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia

Saved in:
Bibliographic Details
Published in:Haematologica (Roma) 2018-07, Vol.103 (7), p.e304-e306
Main Authors: Feugier, Pierre, Aurran, Thérèse, Mahé, Béatrice, Letestu, Remi, Nguyen-Khac, Florence, Cazin, Bruno, Tournilhac, Olivier, Maisonneuve, Hervé, Casasnovas, Olivier, Delmer, Alain, Leblond, Véronique, Royer, Bruno, Corront, Bernadette, Chevret, Sylvie, Delépine, Roselyne, Vaudaux, Sandrine, Van Den Neste, Eric, Béné, Marie-Christine, Cymbalista, Florence, Ross-Weil, Damien, Leprêtre, Stéphane
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2017.183350